BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23360367)

  • 1. Intrathecal apelin-13 produced different actions in formalin test and tail-flick test in mice.
    Lv S; Yang YJ; Hong S; Wang N; Qin Y; Li W; Chen Q
    Protein Pept Lett; 2013 Aug; 20(8):926-31. PubMed ID: 23360367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antinociceptive tolerance to the chronic intrathecal administration of apelin-13 in rat.
    Abbasloo E; Najafipour H; Esmaeili-Mahani S
    Neuropeptides; 2016 Dec; 60():7-12. PubMed ID: 27542441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supraspinal antinociceptive effect of apelin-13 in a mouse visceral pain model.
    Lv SY; Qin YJ; Wang NB; Yang YJ; Chen Q
    Peptides; 2012 Sep; 37(1):165-70. PubMed ID: 22732665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraspinal administration of apelin-13 induces antinociception via the opioid receptor in mice.
    Xu N; Wang H; Fan L; Chen Q
    Peptides; 2009 Jun; 30(6):1153-7. PubMed ID: 19463749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Electroacupuncture on the Apelin/APJ System in the Spinal Cord of Rats With Inflammatory Pain.
    Wang K; Ju Z; Yong Y; Chen T; Song J; Zhou J
    Anesth Analg; 2016 Dec; 123(6):1603-1610. PubMed ID: 27632349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally administered apelin-13 induces depression-like behavior in mice.
    Lv SY; Qin YJ; Wang HT; Xu N; Yang YJ; Chen Q
    Brain Res Bull; 2012 Sep; 88(6):574-80. PubMed ID: 22728209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of centrally administered apelin-13 on gastric emptying and gastrointestinal transit in mice.
    Lv SY; Yang YJ; Qin YJ; Xiong W; Chen Q
    Peptides; 2011 May; 32(5):978-82. PubMed ID: 21291936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain.
    Goettl VM; Larson AA
    Neuroscience; 1994 May; 60(2):375-82. PubMed ID: 7521022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C; Jhamandas K; Sutak M; Zajac JM
    Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive actions of intrathecal xylazine: interactions with spinal cord opioid pathways.
    Goodchild CS; Guo Z; Davies A; Gent JP
    Br J Anaesth; 1996 Apr; 76(4):544-51. PubMed ID: 8652328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential mediation of norepinephrine-and dopamine-induced antinociception at the spinal level: involvement of different local neuroactive substances.
    Yang SW; Zhang C; Zhang ZH; Qiao JT; Dafny N
    Brain Res Bull; 1996; 41(2):105-9. PubMed ID: 8879674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the spinal apelin‑APJ system on the pathogenesis of chronic constriction injury‑induced neuropathic pain in rats.
    Xiong Q; He W; Wang H; Zhou J; Zhang Y; He J; Yang C; Zhang B
    Mol Med Rep; 2017 Aug; 16(2):1223-1231. PubMed ID: 28627589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential actions of the blockade of spinal opioid, adrenergic and serotonergic receptors on the tail-flick inhibition induced by morphine microinjected into dorsal raphe and central gray in rats.
    Tseng LL; Tang R
    Neuroscience; 1989; 33(1):93-100. PubMed ID: 2557562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1993 Jul; 266(1):329-38. PubMed ID: 8101218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
    McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
    Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptors mediate inotropic and depressor effects of apelin in rats with 2K1C-induced chronic renovascular hypertension.
    Rostamzadeh F; Najafipour H; Yeganeh-Hajahmadi M; Joukar S
    Clin Exp Pharmacol Physiol; 2018 Feb; 45(2):187-197. PubMed ID: 28945940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.
    Welch SP; Stevens DL; Dewey WL
    J Pharmacol Exp Ther; 1992 Jan; 260(1):117-27. PubMed ID: 1346158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.